Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ARDELYX, INC. | 430,511 | reported | 21 May 2026 | tx 48+1,402,512−621,997 |
| Enliven Therapeutics, Inc. | 8,500 | reported | 02 Jun 2022 | tx 2+23,957 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | SALE | ARDELYX, INC. | 1,503 | 6.27 USD | |
| 21 May 2026 | SALE | ARDELYX, INC. | 2,157 | 6.27 USD | |
| 21 May 2026 | SALE | ARDELYX, INC. | 1,911 | 6.27 USD | |
| 21 May 2026 | SALE | ARDELYX, INC. | 1,418 | 6.27 USD | |
| 20 Feb 2026 | SALE | ARDELYX, INC. | 984 | 5.71 USD | |
| 20 Feb 2026 | SALE | ARDELYX, INC. | 7,192 | 5.87 USD | |
| 23 Jan 2026 | GRANT_AWARD | ARDELYX, INC. | 82,695 | 0.00 USD | |
| 23 Jan 2026 | GRANT_AWARD | ARDELYX, INC. | 124,040 | 0.00 USD | deriv |
| 08 Jan 2026 | SALE | ARDELYX, INC. | 50,000 | 6.98 USD | |
| 08 Jan 2026 | EXERCISE | ARDELYX, INC. | 50,000 | 0.99 USD | |
| 08 Jan 2026 | EXERCISE | ARDELYX, INC. | 0 | 0.00 USD | deriv |
| 21 Nov 2025 | SALE | ARDELYX, INC. | 6,426 | 5.54 USD | |
| 26 Aug 2025 | SALE | ARDELYX, INC. | 50,000 | 6.12 USD | |
| 26 Aug 2025 | SALE | ARDELYX, INC. | 30,000 | 6.12 USD | |
| 26 Aug 2025 | EXERCISE | ARDELYX, INC. | 50,000 | 0.99 USD | |
| 26 Aug 2025 | EXERCISE | ARDELYX, INC. | 50,000 | 0.00 USD | deriv |
| 21 Aug 2025 | SALE | ARDELYX, INC. | 6,261 | 5.93 USD | |
| 20 May 2025 | SALE | ARDELYX, INC. | 6,421 | 4.08 USD | |
| 25 Feb 2025 | GRANT_AWARD | ARDELYX, INC. | 105,200 | 0.00 USD | |
| 25 Feb 2025 | GRANT_AWARD | ARDELYX, INC. | 157,700 | 0.00 USD | deriv |
| 20 Feb 2025 | SALE | ARDELYX, INC. | 4,941 | 5.62 USD | |
| 20 Nov 2024 | SALE | ARDELYX, INC. | 7,366 | 4.79 USD | |
| 20 Aug 2024 | SALE | ARDELYX, INC. | 7,412 | 5.86 USD | |
| 05 Jun 2024 | EXERCISE | ARDELYX, INC. | 100,000 | 2.75 USD | |
| 05 Jun 2024 | SALE | ARDELYX, INC. | 100,000 | 7.13 USD |